PedAM

Pediatric Disease Annotations & Medicines

Disease	cystic fibrosis
Symptom	\|lung infection
Sentences	73
PubMedID- 22589289	It is also an important opportunistic human pathogen and major contributor to chronic lung infections in patients with cystic fibrosis (cf).
PubMedID- 25596784	cystic fibrosis with chronic lung infection, patients with chronic wound infections) or associated with devices (e.g.
PubMedID- 22798960	The β-hairpin mimetic pol7080 is currently in a phase i clinical trial in europe, and could represent an important drive in the treatment of chronic lung infections in patients with cystic fibrosis where p. aeruginosa plays a crucial role.
PubMedID- 23620120	Abscessus strains from cystic fibrosis patients with clinical lung infection.
PubMedID- 23137712	Treatment of lung infection in patients with cystic fibrosis: current and future strategies.
PubMedID- 20942647	Aeruginosa cell counts in a rat lung infection model and in patients with cystic fibrosis.
PubMedID- 22069491	Pseudomonas aeruginosa is an opportunistic pathogen that causes both acute pneumonitis in immunocompromised patients and chronic lung infections in individuals with cystic fibrosis and other bronchiectasis.
PubMedID- 23737089	Authors' conclusions: we could not identify an antibiotic adjuvant therapy that could be recommended for the treatment of lung infection in those with cystic fibrosis.
PubMedID- 20218338	Identification of possible mechanisms of lung infection in patients with cystic fibrosis will allow to develop evidence-based system of prevention of infectious complications in these patients.
PubMedID- 25830686	Maltophilia lung infection in patients with cystic fibrosis.
PubMedID- 21775220	Novel concepts in evaluating antimicrobial therapy for bacterial lung infections in patients with cystic fibrosis.
PubMedID- 26371010	In practice, biofilms can be found in association with chronic bacterial infections generally, wound infections, chronic lung infections of cystic fibrosis patients, in association with in-dwelling devices such as catheters, or on environmental surfaces, e.g., .
PubMedID- 20837573	Objectives: to test the presumption that pseudomonas aeruginosa isolates responsible for initial lung infection in individuals with cystic fibrosis (cf) are invariably susceptible to antipseudomonal agents.
PubMedID- 23642644	During chronic lung infections of cystic fibrosis (cf) patients pseudomonas aeruginosa adapts by accumulating mutations associated with phenotypic adaptations, leading to populations of p. aeruginosa composed of multiple clones with differing antimicrobial susceptibility profiles .
PubMedID- 22968160	Fluoroquinolones are commonly used to treat lung infections in patients with cystic fibrosis.
PubMedID- 23984384	However, the most serious medical problem caused by p. aeruginosa is lung infection associated with cystic fibrosis 3.
PubMedID- 24064077	Bacterial sinusitis can be a focus for initial lung colonisation and chronic lung infection in patients with cystic fibrosis.
PubMedID- 22196973	Pseudomonas aeruginosa is the major pathogen in chronic lung infections of individuals with cystic fibrosis (cf).
PubMedID- 22905927	Moreover, many chronic infections, like diabetic ulcers or lung infections in patients with cystic fibrosis, result from bacteria growing as biofilms (costerton et al., 1999).
PubMedID- 26517580	Neutrophil-associated inflammation during pseudomonas aeruginosa lung infection is a determinant of morbidity in cystic fibrosis (cf).
PubMedID- 24614401	We used antibiotic therapy of chronic lung infection in persons with cystic fibrosis as a model system to assess the influence of key variables of therapy on measures of microbial community perturbation.
PubMedID- 24260360	A particularly serious medical problem caused by p. aeruginosa is chronic lung infection associated with cystic fibrosis .
PubMedID- 24730990	Bacteria of the burkholderia cepacia complex are the cause of severe lung infections primarily in patients with cystic fibrosis (cf).

Page: 1 2